Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.

Starting soon

Conditions studied: BCLC Stage B Hepatocellular Carcinoma

In brief

The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is: \- What are the survival outcomes among participants aged 18 or older who receive treatment for intermediate-stage hepatocellular carcinoma?

Key facts

Study ID

NCT07449637

Run by

Sohag University

People needed

200

Starts

2026-03-01

Expected to finish

2026-07-01

Last updated by the study team

2026-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥18 years.
• Both sexes.
• Diagnosis of hepatocellular carcinoma based on accepted radiologic or histologic criteria.
• Classified as intermediate stage (BCLC-B) at time of decision for first-line treatment.
• Child-Pugh A or B.
• ECOG performance status 0-1.

You may not qualify if…

• BCLC A, C, or D at diagnosis.
• Prior curative therapy (resection, transplantation, curative ablation).
• Missing essential data (imaging, liver function, treatment records).
• Mixed HCC-cholangiocarcinoma.

Where it is running

• Sohag Oncology Center — Sohag, Sohag Governorate, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.